These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5082475)

  • 21. [Studies on the metabolism of para-aminosalicylic acid in the body. VI. Absorption, tolerance and therapeutic effect of Napashin in double gastro-enteric coating].
    Nikodemowicz E; Owsiñski M; Kamiñska M; Ostrowska A; Rapf T
    Gruzlica; 1971 Nov; 39(11):1113-21. PubMed ID: 5137653
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of isoniazid and PAS on various biochemical indices of liver function in patients with tuberculosis].
    Savula MM; Tytor IaN
    Vrach Delo; 1983 Jul; (7):16-9. PubMed ID: 6624048
    [No Abstract]   [Full Text] [Related]  

  • 23. [Value of the immunological tests in the diagnosis of adverse effects of tuberculostatic therapy].
    Averbakh MM; Keleberda KIa; Gergert VIa; Mingazitinova DM
    Probl Tuberk; 1980 Mar; (3):27-30. PubMed ID: 6994091
    [No Abstract]   [Full Text] [Related]  

  • 24. Intestinal absorption of tolfenamic acid at experimental malabsorption states in rats.
    Senius KE; Fendrich Z; Hradil J
    Arzneimittelforschung; 1981; 31(12):2092-5. PubMed ID: 7199304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Megaloblastic anemia caused by malabsorption of vitamin B12 during long-term metformin therapy].
    Mourits-Andersen T; Ditzel J
    Ugeskr Laeger; 1983 Jan; 145(1):25-6. PubMed ID: 6836759
    [No Abstract]   [Full Text] [Related]  

  • 26. [Secondary manifestations of the antibacterial therapy of tuberculosis in children].
    Frolova VM
    Probl Tuberk; 1967; 45(1):32-6. PubMed ID: 5303088
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypersensitivity reactions to antituberculous drugs in pulmonary tuberculosis].
    Dukalski J; Stański K
    Gruzlica; 1969 Oct; 37(10):937-41. PubMed ID: 5366986
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of pancythopenia following combined therapy with streptomycin and Napashin].
    Oleniacz W; Dzierzkowa-Bordej W
    Gruzlica; 1967 Jan; 35(1):71. PubMed ID: 6044452
    [No Abstract]   [Full Text] [Related]  

  • 29. Malabsorption due to paromomycin.
    Keusch GT; Troncale FJ; Buchanan RD
    Arch Intern Med; 1970 Feb; 125(2):273-6. PubMed ID: 5412015
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J
    Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of dietary gluten upon neomycin-induced malabsorption.
    Levine RA
    Gastroenterology; 1967 Apr; 52(4):685-90. PubMed ID: 6021791
    [No Abstract]   [Full Text] [Related]  

  • 32. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE; Kane S
    Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Resistance effect to the para-amino-salicylic acid and the isoniazid phenyl-para-amino-salicylate].
    Torning K
    Prensa Med Argent; 1966; 53(9):1055-9. PubMed ID: 6004190
    [No Abstract]   [Full Text] [Related]  

  • 34. [Thyroid function disorders in the course of treatment with preparations of para-aminosalicylic acid (PAS)].
    Górowski T; Gasiorowski W
    Pol Tyg Lek; 1967 Aug; 22(33):1239-41. PubMed ID: 6082009
    [No Abstract]   [Full Text] [Related]  

  • 35. [Malabsorption of medicinal origin].
    Dumitraşcu D; Grigorescu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(1):11-5. PubMed ID: 16325
    [No Abstract]   [Full Text] [Related]  

  • 36. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
    Mariani B; Bisetti A; Monzali G
    G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
    [No Abstract]   [Full Text] [Related]  

  • 37. [The treatment of inflammatory intestinal diseases with preparations of 5-aminosalicylic acid].
    Frol'kis AV
    Ter Arkh; 1996; 68(2):75-7. PubMed ID: 8771669
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease].
    García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J
    Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].
    Smilde TJ; van Liebergen FJ; Koolen MI; Gerlag PG; Assmann KJ; Berden JH
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2557-61. PubMed ID: 7830805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Side effects of 5-aminosalicylic acid].
    Marteau P; Cellier C
    Gastroenterol Clin Biol; 1997; 21(5):377-86. PubMed ID: 9208013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.